Microvascular Invasion for Guiding Treatment of Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma

NCT05889949 · clinicaltrials.gov ↗

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Radiomics
Hepatocellular Carcinoma (HCC)
Transcatheter Arterial Chemoembolization (TACE)
Microvascular Invasion (MVI)
Multi-kinase Inhibitors (MKI)

Interventions

DRUG: Sorafenib
DRUG: Lenvatinib

Sponsor

Sun Yat-sen University